Latest Insider Transactions at Eli Lilly & CO (LLY)
This section provides a real-time view of insider transactions for Eli Lilly & CO (LLY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ELI LILLY & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ELI LILLY & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 19
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
121
+1.32%
|
$13,552
$112.53 P/Share
|
|
Aug 19
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.03%
|
$2,016
$112.53 P/Share
|
|
Aug 19
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
110
+10.51%
|
$12,320
$112.53 P/Share
|
|
Jul 15
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
101
+0.23%
|
$10,908
$108.47 P/Share
|
|
Jul 15
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
125
+1.38%
|
$13,500
$108.47 P/Share
|
|
Jul 15
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.03%
|
$2,052
$108.47 P/Share
|
|
Jul 15
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
114
+12.11%
|
$12,312
$108.47 P/Share
|
|
Jul 15
2019
|
Joshua L Smiley |
BUY
Open market or private purchase
|
Direct |
185
+0.6%
|
$19,980
$108.47 P/Share
|
|
Jul 05
2019
|
Leigh Ann Pusey EVP, Corp. Affairs & Comm. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,080
-26.76%
|
$123,120
$114.42 P/Share
|
|
Jul 05
2019
|
Leigh Ann Pusey EVP, Corp. Affairs & Comm. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,394
+37.23%
|
-
|
|
Jun 17
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
87
+10.88%
|
$9,831
$113.4 P/Share
|
|
Jun 17
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.03%
|
$2,034
$113.4 P/Share
|
|
Jun 17
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
120
+1.35%
|
$13,560
$113.4 P/Share
|
|
Jun 17
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
96
+0.22%
|
$10,848
$113.4 P/Share
|
|
Jun 05
2019
|
Joshua L Smiley |
BUY
Open market or private purchase
|
Direct |
426
+1.38%
|
$50,268
$118.03 P/Share
|
|
Jun 03
2019
|
Michael J Harrington Senior VP and General Counsel |
SELL
Open market or private sale
|
Direct |
16,000
-12.67%
|
$1,856,000
$116.72 P/Share
|
|
May 20
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
171
+21.54%
|
$19,836
$116.23 P/Share
|
|
May 20
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.03%
|
$1,972
$116.23 P/Share
|
|
May 20
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
117
+1.34%
|
$13,572
$116.23 P/Share
|
|
May 20
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
94
+0.21%
|
$10,904
$116.23 P/Share
|
|
May 03
2019
|
Christi Shaw SVP and Pres., Lilly Bio-Meds |
SELL
Open market or private sale
|
Direct |
7,577
-96.7%
|
$886,509
$117.54 P/Share
|
|
May 01
2019
|
Christi Shaw SVP and Pres., Lilly Bio-Meds |
SELL
Payment of exercise price or tax liability
|
Direct |
6,173
-44.89%
|
$722,241
$117.04 P/Share
|
|
May 01
2019
|
Christi Shaw SVP and Pres., Lilly Bio-Meds |
BUY
Exercise of conversion of derivative security
|
Direct |
13,750
+50.0%
|
-
|
|
Apr 15
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
88
+0.2%
|
$10,912
$124.08 P/Share
|
|
Apr 15
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
86
+1.0%
|
$10,664
$124.08 P/Share
|
|
Apr 15
2019
|
Ellen R Marram Director |
BUY
Grant, award, or other acquisition
|
Direct |
55
+0.1%
|
$6,820
$124.08 P/Share
|
|
Apr 15
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.03%
|
$1,984
$124.08 P/Share
|
|
Apr 15
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
80
+15.04%
|
$9,920
$124.08 P/Share
|
|
Apr 12
2019
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
SELL
Open market or private sale
|
Direct |
4,735
-17.65%
|
$591,875
$125.15 P/Share
|
|
Apr 12
2019
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
SELL
Open market or private sale
|
Direct |
10,000
-14.75%
|
$1,240,000
$124.65 P/Share
|
|
Apr 05
2019
|
Aarti S. Shah SVP & CIDO |
SELL
Open market or private sale
|
Direct |
1,800
-8.9%
|
$225,000
$125.85 P/Share
|
|
Mar 26
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
205,000
-0.09%
|
$26,855,000
$131.71 P/Share
|
|
Mar 22
2019
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
1,000
-17.87%
|
$128,000
$128.5 P/Share
|
|
Mar 18
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
87
+0.2%
|
$10,875
$125.24 P/Share
|
|
Mar 18
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+1.0%
|
$10,625
$125.24 P/Share
|
|
Mar 18
2019
|
Ellen R Marram Director |
BUY
Grant, award, or other acquisition
|
Direct |
54
+0.1%
|
$6,750
$125.24 P/Share
|
|
Mar 18
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.03%
|
$2,000
$125.24 P/Share
|
|
Mar 18
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
79
+17.52%
|
$9,875
$125.24 P/Share
|
|
Mar 15
2019
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
SELL
Bona fide gift
|
Direct |
1,815
-8.22%
|
-
|
|
Mar 12
2019
|
Stephen F Fry SVP, HR & Diversity |
SELL
Open market or private sale
|
Direct |
14,847
-11.92%
|
$1,826,181
$123.16 P/Share
|
|
Mar 06
2019
|
Aarti S. Shah SVP & CIDO |
SELL
Bona fide gift
|
Direct |
1,105
-6.0%
|
-
|
|
Mar 01
2019
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
1,000
-15.16%
|
$127,000
$127.01 P/Share
|
|
Mar 01
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.06%
|
$26,880,000
$128.32 P/Share
|
|
Feb 28
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
200,000
-0.09%
|
$25,400,000
$127.01 P/Share
|
|
Feb 22
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
195,000
-0.17%
|
$24,180,000
$124.19 P/Share
|
|
Feb 19
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
205,000
-0.09%
|
$25,010,000
$122.77 P/Share
|
|
Feb 19
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
81
+21.72%
|
$9,882
$122.13 P/Share
|
|
Feb 19
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.03%
|
$1,952
$122.13 P/Share
|
|
Feb 19
2019
|
Ellen R Marram Director |
BUY
Grant, award, or other acquisition
|
Direct |
55
+0.1%
|
$6,710
$122.13 P/Share
|
|
Feb 19
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
87
+1.04%
|
$10,614
$122.13 P/Share
|